Interoperability assessment at EMA

The European Medicines Agency (EMA) is making interoperability assessment reports available in compliance with the Interoperable Europe Act. This legislation is a cooperation framework for public administrations across the European Union (EU). It aims to build a secure cross-border exchange of data and adopt shared digital solutions such as open-source software and IT tools.
Corporate Data on medicines Medicine shortages Medicines

Interoperability between EU institutions and public sector bodies in EU Member States refers to their ability to share data, information and knowledge through digital processes.

Interoperability assessments aim to identify and consider digital and interoperability aspects early in the design phase of policies and digital public services.

The Interoperable Europe Act requires EU institutions and public sector bodies in EU Member States to make interoperability assessments available before taking decisions on new or modified requirements for trans-European digital public services.

The Act enables public administrations to share and reuse solutions, and exchange data. It does so by removing unnecessary administrative burden related to legal, organisational, semantical and technical interoperability obstacles. This helps reduce cost and time for citizens, businesses and for the public sector itself. 

The European Commission's interoperability assessments portal generates and hosts this type of reports. EMA makes them available via the 'EMA interoperability assessment reports' section on this page.

To find out more about EMA, see:

Share this page